Tirzepatide trend
Searches for tirzepatide rose +62% over the last 12 months on Google, and Bluesky posts and research papers (OpenAlex) rose with them.
Updated · Google Trends and 2 sources outside Google
Is tirzepatide still growing?
Yes. Google's weekly index for it is up +62% in a year, and still up +7% over the last 3 months. The rise is measured, not a one-week spike or a change in how Google counts, and Bluesky posts and research papers (OpenAlex) rose with it, each above what every other search on the same source did.
- 3 months
- +7%
- 1 year
- +62%
- 2 years
- +208%
Each figure compares Google's weekly index at the end of the window with its start. Searches usually peak in June.
Checked outside Google
A rise on Google alone can be a change in how Google counts. These rose with it, each against what every other search on the same source did:
- Bluesky posts (tirzepatide): 68 → 162 out of 100 (weekly average), +138% on the year against a library median of +21%
- research papers (OpenAlex): 920 → 1,990 papers a year, +116% on the year against a library median of +31%
Also searched as
The same search in other words, each passing the same check on its own.
- glp-1 tirzepatide: +237% in a year, with Bing searches rising too
About this search
Tirzepatide refers to the Eli Lilly drug sold as Mounjaro for type 2 diabetes and Zepbound for weight loss and sleep apnoea, a weekly injection that acts on GLP-1 and GIP receptors. People search it to learn what it is, its price, its side effects and how it compares with semaglutide, Wegovy and the newer retatrutide. In practice patients, telehealth platforms and compounding pharmacies create the demand. Its strong weight-loss results have made it one of the best-selling drugs in the world. It anchors a huge market for prescribing, pricing, coaching and adherence services.
Rising alongside it
Searches Google lists as rising with tirzepatide.
- embody
- embody reviews
- embody tirzepatide reviews
- embody tirzepatide
- medvi quad
- shop lc
- shoplc
- medvi quad reviews
More rising in Health
- GLP-1 near me trend+307% in a year
- GLP-1 cost trend+46% in a year
- Does red light therapy really work trend+29% in a year
- Longevity medicine trend+60% in a year
- Longevity clinic trend+174% in a year
Get the week's rising searches
Next Big checks every rise against a second source before it calls it a trend. Join the waitlist: we open it to a few people at a time.
Data as of October 12, 2026 · first seen September 22, 2026 · all rising trends · week of October 12, 2026